Gregg Davis

Vice President, Business Development

Gregg Davis joined Arcutis in October 2024 as vice president business development. Mr Davis is a proven deal maker with over 20 years of experience sourcing, negotiating, and executing complex corporate transactions in the life science space. Mr Davis has a robust deal sheet that includes buy-side and sell-side transactions for clinical stage and approved drugs, discovery and delivery platforms, manufacturing technologies and commercial partnerships. His closed deals include licensing agreements, acquisitions, divestments, JVs, and R&D collaborations. Prior to Arcutis, Mr Davis held business development and corporate development roles of increasing responsibility at various biopharma companies including GSK, Patheon (now Thermo Fisher), Affinia Therapeutics, AskBio, and Avadel Pharmaceuticals. He started his career as a sales rep at Janssen, transitioned to new product strategy and marketing positions at Glaxo Wellcome (now GSK) and venture capital backed start-ups. Mr Davis holds a BA in Economics and an MBA from the University of North Carolina at Chapel Hill.